Basal/squamous and mixed subtype bladder cancers present poor outcomes after neoadjuvant chemotherapy in the VESPER trial
2024 · Annals of Oncology · 25 citations
https://doi.org/10.1016/j.annonc.2024.09.008
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
5
Papers
25
Citations
1
h-index
1
i10-index
F. Radvanyi is an academic researcher from Centre National de la Recherche Scientifique. The author has contributed to research in topics: Bladder and Urothelial Cancer Treatments & Inflammatory Biomarkers in Disease Prognosis & Cancer, Lipids, and Metabolism. The author has an h-index of 1, co-authored 5 publications.
https://doi.org/10.1016/j.annonc.2024.09.008
https://doi.org/10.1016/s2666-1683(24)01393-4
Click to start Chat